Dr. Liang C. Dong   CEO & CSO

Dr. Liang C. Dong, co-founder, Chairman, and CEO of WD Pharma, holds a Ph.D. from the Department of Bioengineering at the University of Washington in the United States. Dr. Dong has extensive experience in the development of novel drug delivery platforms and 505(b)(2) products. Dr. Dong has held senior management positions such as Senior Research Fellow and Director of Oral Products at ALZA and Johnson & Johnson. Dr. Dong is an inventor on more than 100 patents, including more than 50 issued U.S. patents.

Dr. Jim Wei  CMO

Dr. Jim Wei, co-founder, CMO of WD Pharma, mentored by Prof. Dr. Robert Vestal; completed postdoctoral studies at the University of Washington and the National Cancer Institute. 

• 10 years of work experience in the Office of Clinical Pharmacology at the FDA's Center for Drug Evaluation and Research (CDER); recipient of the U.S. FDA Outstanding Service Award and the Frances O. Kelsey Award for Drug Safety. 

• 10 years of work experience at Medpace as Senior Medical Director for early phase clinical development. 

• Over 30 years of professional experience in clinical trials and regulatory submissions in various countries and regions.”

Dr. Jingmin Shi Deputy General Manager, Quality Director

Dr. Jingmin Shi, a founding member and VP of WD Pharma, holds master of pharmacology from Fudan University School of Medicine, Ph.D. in clinical pharmacology from Shanghai University of Traditional Chinese Medicine, postdoctoral fellow at the National Institutes of Health (NIH) in the United States, and a visiting scholar at Novartis Pharmaceuticals.

• Deputy Chief Pharmacist, member of the Clinical Pharmacology Committee of the Shanghai Pharmaceutical Association; formerly served as the head of the Pharmacology and Toxicology Department of the Shanghai Institute for Drug Control, director of the Toxicokinetics Department at the Center for Drug Safety Evaluation, and an on-site inspection expert at the Shanghai Municipal Food and Drug Administration.

• She specializes in pharmacokinetics and bioanalysis, with over 30 SCI (Science Citation Index) publications, and has extensive experience in research and development, patenting, and quality management.

Jing Fang Deputy General Manager, CFO

Ms. Jing Fang, CFO of WD Pharma, holds a bachelor's degree in finance. She is a certified public accountant, an enterprise risk management professional, and has a professional qualification in financial management for corporate leaders.

• She has over 20 years of experience in standardized financial management, equity investment management, and real estate management within large state-owned enterprises.

• Served as a Chief Financial Officer (CFO) and Deputy General Manager in several domestic and Hong Kong-listed pharmaceutical companies, with extensive operational management experience in the pharmaceutical industry.

• Member of the CPPCC (Chinese People's Political Consultative Conference) in Pudong New Area.